IMUX NASDAQ
Immunic, Inc.
1W: -14.9%
1M: -44.1%
3M: -46.4%
YTD: +36.5%
1Y: -17.1%
3Y: -45.5%
5Y: -91.4%
$7.96
-0.68 (-7.87%)
Weekly Expected Move ±10.2%
$6
$7
$8
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-03-31
Earliest Filing
2021-03-31
Latest Filing
partner: 1
Counterparties (Filed by IMUX)
1 relationshipsCompanies named in IMUX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| 4SC AG | — | partner | Settlement agreement executed to resolve royalty obligations for IMU-838 asset acquisition. | 2021-03-31 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-11 | Officer/Director Change; Exhibits | View | |
| 2026-09-09 | Regulation FD; Exhibits | View | |
| 2026-08-11 | Earnings Release; Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-07-14 | Regulation FD; Exhibits | View | |
| 2026-07-06 | Officer/Director Change | View | |
| 2026-06-29 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-28 | Regulation FD; Exhibits | View | |
| 2026-05-27 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-19 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-04-28 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-04-23 | Bylaws Amendment; Other Events; Exhibits | View | |
| 2026-04-14 | Shareholder Vote; Other Events | View | |
| 2026-04-10 | Officer/Director Change; Exhibits | View | |
| 2026-04-01 | Other Events; Exhibits | View | |
| 2026-03-31 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-13 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Departure/Electio | Agreement | View |
| 2026-01-06 | Notice of Delisting or Transfer | View | |
| 2026-01-05 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR